Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah Casey

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Therapeutic Advances in Respiratory Disease|April 4, 2023
Creatine kinase levels in asthma patients receiving interleukin-5 therapyGrace A Kavanagh, Deborah Casey, Ruth P Cusack, et al.
Frontiers in Allergy|January 23, 2023
Real-World clinical outcomes of asthma patients switched from reslizumab to mepolizumab or benralizumabLaura J Walsh, Deborah Casey, Punitha Vairamani, et al.
Journal of Affective Disorders|February 19, 2021
Self-harm during the early period of the COVID-19 pandemic in England: Comparative trend analysis of hospital presentationsKeith Hawton, Deborah Casey, Elizabeth Bale, et al.
Journal of Psychiatric Research|March 28, 2021
Self-harm and the COVID-19 pandemic: A study of factors contributing to self-harm during lockdown restrictionsKeith Hawton, Karen Lascelles, Fiona Brand, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 3, 2024
The use of monoclonal therapy in the treatment of near-fatal asthma complicated by steroid sensitivity: A case reportPatrick Coghlan, Grace Kavanagh, Aoife Broderick, et al.
The Lancet. Psychiatry|September 12, 2017
General hospital costs in England of medical and psychiatric care for patients who self-harm: a retrospective analysisApostolos Tsiachristas, David McDaid, Deborah Casey, et al.
Clinical Practice and Epidemiology in Mental Health : CP & EMH|September 25, 2007
The effect of using NHS number as the unique identifier for patients who self-harm: a multi-centre descriptive studyJayne Cooper, Elizabeth Murphy, Helen Bergen, et al.
Journal of Asthma and Allergy|July 18, 2022
Real-World Clinical Outcomes in Asthmatic Patients Switched from Omalizumab to Anti-Interleukin-5 TherapyEmily O'Reilly, Deborah Casey, Hisham Ibrahim, et al.
Journal of Affective Disorders|September 3, 2020
Paracetamol self-poisoning: Epidemiological study of trends and patient characteristics from the multicentre study of self-harm in EnglandDeborah Casey, Galit Geulayov, Elizabeth Bale, et al.
Epidemiology and Psychiatric Sciences|March 13, 2020
Incidence and general hospital costs of self-harm across England: estimates based on the multicentre study of self-harmApostolos Tsiachristas, Galit Geulayov, Deborah Casey, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Therapeutic Advances in Respiratory Disease|April 4, 2023
Creatine kinase levels in asthma patients receiving interleukin-5 therapyGrace A Kavanagh, Deborah Casey, Ruth P Cusack, et al.
Frontiers in Allergy|January 23, 2023
Real-World clinical outcomes of asthma patients switched from reslizumab to mepolizumab or benralizumabLaura J Walsh, Deborah Casey, Punitha Vairamani, et al.
Journal of Affective Disorders|February 19, 2021
Self-harm during the early period of the COVID-19 pandemic in England: Comparative trend analysis of hospital presentationsKeith Hawton, Deborah Casey, Elizabeth Bale, et al.
Journal of Psychiatric Research|March 28, 2021
Self-harm and the COVID-19 pandemic: A study of factors contributing to self-harm during lockdown restrictionsKeith Hawton, Karen Lascelles, Fiona Brand, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 3, 2024
The use of monoclonal therapy in the treatment of near-fatal asthma complicated by steroid sensitivity: A case reportPatrick Coghlan, Grace Kavanagh, Aoife Broderick, et al.
The Lancet. Psychiatry|September 12, 2017
General hospital costs in England of medical and psychiatric care for patients who self-harm: a retrospective analysisApostolos Tsiachristas, David McDaid, Deborah Casey, et al.
Clinical Practice and Epidemiology in Mental Health : CP & EMH|September 25, 2007
The effect of using NHS number as the unique identifier for patients who self-harm: a multi-centre descriptive studyJayne Cooper, Elizabeth Murphy, Helen Bergen, et al.
Journal of Asthma and Allergy|July 18, 2022
Real-World Clinical Outcomes in Asthmatic Patients Switched from Omalizumab to Anti-Interleukin-5 TherapyEmily O'Reilly, Deborah Casey, Hisham Ibrahim, et al.
Journal of Affective Disorders|September 3, 2020
Paracetamol self-poisoning: Epidemiological study of trends and patient characteristics from the multicentre study of self-harm in EnglandDeborah Casey, Galit Geulayov, Elizabeth Bale, et al.
Epidemiology and Psychiatric Sciences|March 13, 2020
Incidence and general hospital costs of self-harm across England: estimates based on the multicentre study of self-harmApostolos Tsiachristas, Galit Geulayov, Deborah Casey, et al.
Pageof 5